Medical breakthroughs, looser FDA made biotech stocks one of the decade’s best investments

Medical breakthroughs, looser FDA made biotech stocks one of the decade’s best investments

Biotech stocks fell 40% by February 2016 and only very slowly recovered. But signs of better growth emerged late in 2019. Though the ETF has yet to return to its 2015 high, the industry’s equity has …